493 related articles for article (PubMed ID: 27197876)
1. The German ROP Registry: data from 90 infants treated for retinopathy of prematurity.
Walz JM; Bemme S; Pielen A; Aisenbrey S; Breuß H; Alex AF; Wagenfeld L; Schiedel S; Krohne TU; Stahl A;
Acta Ophthalmol; 2016 Dec; 94(8):e744-e752. PubMed ID: 27197876
[TBL] [Abstract][Full Text] [Related]
2. Treated Cases of Retinopathy of Prematurity in Germany: 10-Year Data from the Retina.net Retinopathy of Prematurity Registry.
Pfeil JM; Barth T; Lagrèze WA; Lorenz B; Hufendiek K; Liegl R; Breuss H; Bemme S; Aisenbrey S; Glitz B; Süsskind D; Gabel-Pfisterer A; Skevas C; Krohne TU; Kakkassery V; Bründer MC; Engelmann K; Guthoff R; Walter P; Choritz L; Stahl A;
Ophthalmol Retina; 2024 Jun; 8(6):579-589. PubMed ID: 38104929
[TBL] [Abstract][Full Text] [Related]
3. [Treated cases of retinopathy of prematurity in Germany : 5-year data from the Retina.net ROP registry].
Walz JM; Bemme S; Reichl S; Akman S; Breuß H; Süsskind D; Glitz B; Müller VC; Wagenfeld L; Gabel-Pfisterer A; Aisenbrey S; Engelmann K; Koutsonas A; Krohne TU; Stahl A;
Ophthalmologe; 2018 Jun; 115(6):476-488. PubMed ID: 29637302
[TBL] [Abstract][Full Text] [Related]
4. [Epidemiology and treatment of retinopathy of prematurity. The Hannover data in the Retina.net ROP registry from 2001-2017].
Akman SH; Pfeil JM; Stahl A; Ehlers S; Böhne C; Bohnhorst B; Framme C; Brockmann D; Bajor A; Jacobsen C; Hufendiek K; Pielen A;
Ophthalmologe; 2022 May; 119(5):497-505. PubMed ID: 34811591
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of intravitreal bevacizumab for zone-II retinopathy of prematurity.
Karkhaneh R; Khodabande A; Riazi-Eafahani M; Roohipoor R; Ghassemi F; Imani M; Dastjani Farahani A; Ebrahimi Adib N; Torabi H
Acta Ophthalmol; 2016 Sep; 94(6):e417-20. PubMed ID: 27009449
[TBL] [Abstract][Full Text] [Related]
6. Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity.
Sankar MJ; Sankar J; Mehta M; Bhat V; Srinivasan R
Cochrane Database Syst Rev; 2016; 2():CD009734. PubMed ID: 26932750
[TBL] [Abstract][Full Text] [Related]
7. Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity.
Sankar MJ; Sankar J; Chandra P
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD009734. PubMed ID: 29308602
[TBL] [Abstract][Full Text] [Related]
8. Treatment for retinopathy of prematurity in Sweden 2008-2021: Reduced gestational age of treated infants and remaining differences in treatment type and recurrence rates between hospitals.
Holmström G; Hellström A; Teär Fahnehjelm K; Gränse L; Sandgren Hochhard K; Sunnqvist B; Tornqvist K; Tsamadou D; Wallin A; Larsson E
Acta Ophthalmol; 2024 Jun; 102(4):401-408. PubMed ID: 37698061
[TBL] [Abstract][Full Text] [Related]
9. [Effects of intravitreal pegaptanib or bevacizumab and laser in treatment of threshold retinopathy of prematurity in zone I and posterior zone II--four years results].
Autrata R; Senková K; Holousová M; Krejcírová I; Dolezel Z; Borek I
Cesk Slov Oftalmol; 2012 Feb; 68(1):29-36. PubMed ID: 22679695
[TBL] [Abstract][Full Text] [Related]
10. Retinal Detachment after Treatment of Retinopathy of Prematurity with Laser versus Intravitreal Anti-Vascular Endothelial Growth Factor.
Barry GP; Yu Y; Ying GS; Tomlinson LA; Lajoie J; Fisher M; Binenbaum G;
Ophthalmology; 2021 Aug; 128(8):1188-1196. PubMed ID: 33387554
[TBL] [Abstract][Full Text] [Related]
11. Outcomes after Intravitreal Bevacizumab versus Laser Photocoagulation for Retinopathy of Prematurity: A 5-Year Retrospective Analysis.
Hwang CK; Hubbard GB; Hutchinson AK; Lambert SR
Ophthalmology; 2015 May; 122(5):1008-15. PubMed ID: 25687024
[TBL] [Abstract][Full Text] [Related]
12. RATES AND RISK FACTORS FOR RECURRENCE OF RETINOPATHY OF PREMATURITY AFTER LASER OR INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR MONOTHERAPY.
Ling KP; Liao PJ; Wang NK; Chao AN; Chen KJ; Chen TL; Hwang YS; Lai CC; Wu WC
Retina; 2020 Sep; 40(9):1793-1803. PubMed ID: 31800460
[TBL] [Abstract][Full Text] [Related]
13. Reactivation of retinopathy of prematurity after ranibizumab treatment.
Wong RK; Hubschman S; Tsui I
Retina; 2015 Apr; 35(4):675-80. PubMed ID: 25768252
[TBL] [Abstract][Full Text] [Related]
14. Five years of treatment for retinopathy of prematurity in Sweden: results from SWEDROP, a national quality register.
Holmström G; Hellström A; Jakobsson P; Lundgren P; Tornqvist K; Wallin A
Br J Ophthalmol; 2016 Dec; 100(12):1656-1661. PubMed ID: 26969711
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Bevacizumab, Ranibizumab, and Laser Photocoagulation in the Treatment of Retinopathy of Prematurity in Turkey.
Gunay M; Sukgen EA; Celik G; Kocluk Y
Curr Eye Res; 2017 Mar; 42(3):462-469. PubMed ID: 27420302
[TBL] [Abstract][Full Text] [Related]
16. Comparability of input parameters in the German Retina.net ROP registry and the EU-ROP registry - An exemplary comparison between 2011 and 2021.
Winter K; Pfeil JM; Engmann H; Aisenbrey S; Lorenz B; Hufendiek K; Breuss H; Khattab M; Süsskind D; Kakkassery V; Lagrèze WA; Barth T; Liegl R; Bründer MC; Skevas C; Goldammer I; Glitz B; Michalewicz E; Krohne TU; Bartmann IR; Stahl A;
Acta Ophthalmol; 2024 May; 102(3):e314-e321. PubMed ID: 37725047
[TBL] [Abstract][Full Text] [Related]
17. Treatment trends for retinopathy of prematurity in the UK: active surveillance study of infants at risk.
Adams GG; Bunce C; Xing W; Butler L; Long V; Reddy A; Dahlmann-Noor AH
BMJ Open; 2017 Mar; 7(3):e013366. PubMed ID: 28325857
[TBL] [Abstract][Full Text] [Related]
18. Time to consider a new treatment protocol for aggressive posterior retinopathy of prematurity?
Spandau U; Tomic Z; Ewald U; Larsson E; Akerblom H; Holmström G
Acta Ophthalmol; 2013 Mar; 91(2):170-5. PubMed ID: 22268644
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal pegaptanib combined with diode laser therapy for stage 3+ retinopathy of prematurity in zone I and posterior zone II.
Autrata R; Krejcírová I; Senková K; Holoušová M; Doležel Z; Borek I
Eur J Ophthalmol; 2012; 22(5):687-94. PubMed ID: 22669848
[TBL] [Abstract][Full Text] [Related]
20. Buckling surgery and supplemental intravitreal bevacizumab or photocoagulation on stage 4 retinopathy of prematurity eyes.
Futamura Y; Asami T; Nonobe N; Kachi S; Ito Y; Sato Y; Hayakawa M; Terasaki H
Jpn J Ophthalmol; 2015 Nov; 59(6):378-88. PubMed ID: 26265249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
